Search

everythinglearnresearchcommunity

for

Search:↓

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

HIV can cause unusual and severe skin problems that are hard to treat.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Histone modification is key in treating chronic inflammatory skin diseases.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

TNF-alpha inhibitors can cause various immune-related skin issues.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

The extracellular matrix affects where tumors can start in the body.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.